PW Armstrong

Efficacy and safety of tenecteplase in combination with the low-molecular-weight heparin enoxaparin or unfractionated heparin in the prehospital setting: the Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT)-3 PLUS randomized trial in acute myocardial infarction (2003)

Goldstein, P, Armstrong, PW, Granger, CB, Adgey, AAJ, Arntz, HR, ...

BACKGROUND: The combination of a single-bolus fibrinolytic and a low-molecular-weight heparin may facilitate prehospital reperfusion and further improve clinical outcome in patients with ST-elevation...

Different outcomes in patients with ST-elevation myocardial infarction among countries with different gross national income (2003)

Orlandini, A, Pieper, KS, Armstrong, PW, Van De Werf, Frans; U0009589, White, HD, Simes, J, ...

Impact of Enoxaparin and Abciximab on Bleeding Complications in Acute Myocardial Infarction: Insights From ASSENT-3 (2002)

Fioretti, PM, Lúpez-Sendún, JL, Verheugt, FW, Meyer, J, Toutouzas, P, ...

The nature and outcome of patients who avoid myocardial necrosis after fibrinolysis (2001)

Armstrong, PW, Fu, Y, Goodman, SG, Van De Werf, Frans; U0009589, Granger, CB

Single-bolus tenecteplase and front-loaded alteplase remain equivalent afte rone year: follow-up results of the ASSENT-2 trial (2000)

Granger, G, Barbash, GI, Armstrong, PW, Ardissino, D, Wallentin, L, ...